Core Insights - Company achieved a revenue of 299 million yuan, representing a year-on-year growth of 30% [2] - Gross profit reached 154 million yuan, with a year-on-year increase of 27%, resulting in a gross margin of 51.5% [2] - R&D investment amounted to 134 million yuan, accounting for 45% of revenue, highlighting the company's commitment to innovation [2] Product Development - The core achievement of the R&D investment is the Spark Medical Model, which is the only large model trained on domestic computing power, ranking first in the Medbench evaluation [2] - The upgraded Spark Medical Model X1, launched in July, demonstrates advanced capabilities in general medical tasks, maintaining a significant industry lead [2] Strategic Positioning - Company is leveraging its leading position in medical AI technology and the broad coverage of its mature products to capitalize on the accelerating growth of the AI healthcare industry [3] - Future strategies include focusing on technological breakthroughs and deepening application scenarios to enhance healthcare services and provide efficient diagnostic tools for doctors [3]
讯飞医疗发布2025年中期业绩：实现营收2.99亿元 同比增长30%
Zheng Quan Ri Bao·2025-08-21 07:43